Cresemba

Chemical Nameisavuconazonium sulfate
Dosage FormCapsule (oral; 186 mg); injection (intravenous; 372 mg)
Drug ClassAntifungals
SystemDigestive, Skin, Respiratory, Nervous
CompanyAstellas Pharma Inc.
Approval Year2015

Indication

  • To treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections.
Last updated on 10/27/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Cresemba (isavuconazonium sulfate) Prescribing Information2019Astellas Pharma US, Inc., Northbrook, IL